Posts Tagged ‘plasma cell leukemia’

Friday December 14th, 2012

IDIBAPS – Hospital Clínic investigators lead a consensus statement on Plasma cell leukemia

Plasma cell leukemia (PCL) is a rare and aggressive variant of myeloma characterized by the presence of circulating plasma cells. It is classified as either primary PCL occurring at diagnosis or as secondary PCL in patients with relapsed/refractory myeloma. A consensus statement about this disease, to be published in Leukemia, focuses on diagnostic requirements, response criteria, and treatment recommendations. Dr Carlos Fernández de Larrea, a postdoc investigator at the IDIBAPS team Hematological oncology and the Department of Hematology of the Hospital Clínic de Barcelona, is the first author of this document by the international myeloma working group (IMWG). Dr. Joan Bladé, another IDIBAPS – Hospital Clínic specialist, is also among the authors.

Read the rest of this entry »

Comments Closed